Northwestern Mutual Wealth Management
ABVC icon

Northwestern Mutual Wealth Management’s ABVC BioPharma ABVC Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-150
Closed -$456 – 4006
2025
Q3 		$456 Buy
+150
New +$461 ﹤0.01% 3641

Other funds holding ABVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwestern Mutual Wealth Management's ABVC Position: Q4 2025 in Review

Northwestern Mutual Wealth Management sold out of ABVC BioPharma (ABVC) in Q4 2025, closing a stake of 150 shares — an estimated $456 sold.

Northwestern Mutual Wealth Management first reported a position in ABVC in Q3 2025 and held it in 1 quarter. The position peaked at $456 in Q3 2025. 14 funds tracked by Wall St. Rank hold ABVC as of Q4 2025.

  • Northwestern Mutual Wealth Management reported no remaining ABVC BioPharma position as of Q4 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 150 ABVC BioPharma shares in Q4 2025, an estimated $456.
  • Northwestern Mutual Wealth Management first reported a position in ABVC BioPharma in Q3 2025 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's ABVC BioPharma position peaked at $456 in Q3 2025.
  • 14 funds tracked by Wall St. Rank held ABVC BioPharma as of Q4 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.